Radiopharma rivals ITM and Telix merge after FDA rejection
Two leading radiopharmaceutical companies are joining forces just as one of them absorbs a surprise regulatory setback.
Clinical AI, drug discovery, devices, and regulatory approvals.
Two leading radiopharmaceutical companies are joining forces just as one of them absorbs a surprise regulatory setback.
A new device could make post-prostatectomy incontinence easier to manage by allowing men to control an artificial urinary sphincter remotely.
A new study links irregular and persistently elevated cortisol patterns in saliva to cognitive decline over an 11-year period, with notable differences for Black participants.
A new opinion piece argues that the rise of physician-led political activism risks eroding patient trust and repeats historical mistakes in medicine.
Laboratory scientists across West Africa are pressing governments to bolster disease surveillance as regional health systems deteriorate.
A MedPage Today essay argues that the nation's belief in limitless possibility has historically made it fertile ground for medical fraud.
A weekly medical podcast episode highlights two research areas: oxygen management for preterm infants and a top-down treatment strategy for Crohn's disease.
Italian health authorities report that rising temperatures and longer warm seasons are enabling mosquitoes to transmit West Nile virus across a wider area and for more months each year.
A new report describes how bundled nerve fibers connect different levels of brain organization to support broad mental abilities.
The religious group now permits certain blood-derived medical products while maintaining its prohibition on whole-blood transfusions.
A confirmed fatality marks a new milestone in Florida's severe dengue surge, underscoring the outbreak's growing toll.
As suicide numbers hit historic highs in Argentina, relatives and mental health experts are urging public conversation to address the crisis.
A MedPage Today opinion piece argues that nurse practitioner education should require prior registered nurse work experience to protect the profession's integrity.
A new review argues that rising malaria cases and drug resistance demand a portfolio of interventions, not one magic solution.
A new study shows that people deaf from an early age develop enhanced peripheral vision, a neural adaptation that may act as a built-in danger detector.
A new La Trobe University report shows that despite treatment advances, some people remain vulnerable because of uneven access to testing and prevention.
England and Wales' drug value assessor now deems AstraZeneca and Daiichi Sankyo's antibody drug conjugate cost-effective for NHS use in advanced HER2-low breast cancer.
Bristol Myers Squibb has terminated its $100 million deal with Orum Therapeutics after reviewing phase 1 data for the degrader-antibody conjugate.